A Study to Determine the Efficacy and Safety of Luspatercept in Adult Participants and to Evaluate the Safety and Pharmacokinetics in and Adolescent Participants With Alpha (α)-Thalassemia
Clinical trial NCT05664737 · RECRUITING
Trial details
- NCT number
- NCT05664737
- Sponsor
- Bristol-Myers Squibb
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-09
- Primary completion
- 2027-07-16
- Enrollment
- 189
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.